Duodenal Hematoma

Comprehensive Clinical Guide: Duodenal Hematoma

1. Introduction and Clinical Overview

A duodenal hematoma (DH), specifically an intramural duodenal hematoma (IDH), is a rare but clinically significant condition characterized by the accumulation of blood within the wall of the duodenum. While the duodenum is relatively protected in the retroperitoneum, its fixed position against the vertebral column makes it susceptible to shear forces during blunt abdominal trauma.

Though historically associated with high-impact trauma, the clinical landscape of IDH has evolved. We now recognize a growing incidence of spontaneous IDH, often linked to coagulopathies, anticoagulant therapy, or endoscopic interventions. If left undiagnosed or mismanaged, a duodenal hematoma can progress to duodenal obstruction, leading to persistent vomiting, electrolyte imbalances, and, in severe cases, sepsis or perforation.

2. Etiology and Pathophysiology

Etiology

The etiology of duodenal hematoma is traditionally bifurcated into traumatic and non-traumatic categories.

• Traumatic Causes:
  • Blunt Abdominal Trauma (BAT): Classic mechanism involving bicycle handlebar injuries, motor vehicle accidents (steering wheel impact), or assault.
  • Iatrogenic: Complications arising from endoscopic procedures, specifically Endoscopic Retrograde Cholangiopancreatography (ERCP), endoscopic biopsies, or sphincterotomy.
• Non-Traumatic (Spontaneous) Causes:
  • Coagulopathy: Patients on long-term anticoagulation (Warfarin, NOACs) or those with underlying hematologic disorders (hemophilia, von Willebrand disease).
  • Pancreatitis: Acute pancreatitis can lead to vascular erosion or local inflammation affecting the duodenal wall.
  • Vascular Malformations: Rare instances of ruptured pseudoaneurysms within the duodenal wall.

Pathophysiology

The duodenum consists of four layers: mucosa, submucosa, muscularis propria, and serosa. An IDH typically occurs within the submucosal layer. Because the submucosa is relatively loose connective tissue, it allows for the rapid expansion of a hematoma. As the hematoma grows, it encroaches upon the duodenal lumen, creating a "target sign" or "coiled spring" appearance on imaging, eventually causing a high-grade mechanical small bowel obstruction.

3. Clinical Staging and Grading

Clinical management is dictated by the severity of the obstruction and the presence of associated visceral injuries. A common classification system for IDH involves assessing the degree of luminal compromise.

4. Standard Clinical Presentation

The presentation of a patient with an IDH is often delayed. It is not uncommon for symptoms to manifest 24 to 72 hours after the initial inciting event.

• Classic Triad: Epigastric pain, persistent bilious vomiting, and signs of gastric outlet obstruction.
• Physical Examination:
  • Epigastric tenderness or fullness.
  • Succussion splash (suggesting gastric distension).
  • Signs of dehydration (tachycardia, dry mucous membranes).
  • Absence of peritoneal signs (unless perforation has occurred).

5. Differential Diagnosis

Because the symptoms mimic other acute abdominal processes, the clinician must maintain a high index of suspicion.

1. Peptic Ulcer Disease (PUD): Often presents with similar epigastric pain but usually lacks the obstructive pattern of an IDH.
2. Acute Pancreatitis: Can cause duodenal compression but is usually accompanied by elevated lipase/amylase and characteristic CT findings of pancreatic edema.
3. Superior Mesenteric Artery (SMA) Syndrome: Involves compression of the third part of the duodenum, but usually occurs in the context of rapid weight loss.
4. Duodenal Tumor: A slow-growing obstruction that appears on imaging as a mass rather than a hematoma.
5. Cholecystitis: Right upper quadrant pain that may radiate, but typically lacks the gastric outlet obstruction component.

6. Diagnostic Testing and Imaging Modalities

Computed Tomography (CT)

CT scan with intravenous contrast is the gold standard for diagnosis.
* Key Findings: A hyperdense (bright) intramural mass involving the duodenal wall.
* The "Coiled Spring" Sign: Thickened mucosal folds compressed by the submucosal hematoma.
* Contrast Enhancement: Lack of internal enhancement within the hematoma distinguishes it from a tumor or abscess.

Endoscopy (EGD)

Used when the diagnosis is uncertain.
* Appearance: A bluish or dark-colored submucosal bulge.
* Caution: Biopsy is contraindicated if a hematoma is suspected, as it risks iatrogenic perforation or hemorrhage.

Laboratory Investigations

• Coagulation Profile (PT/INR/PTT): Essential to rule out underlying coagulopathy.
• Amylase/Lipase: To rule out concurrent pancreatitis.
• Electrolytes/BUN/Creatinine: To assess the degree of dehydration and metabolic alkalosis resulting from persistent vomiting.

7. Management and Prognosis

Conservative Management (The Preferred Standard)

Most intramural duodenal hematomas resolve spontaneously.
* Bowel Rest: NPO (nothing by mouth).
* Gastric Decompression: Nasogastric (NG) tube to suction to relieve the stomach and duodenum.
* Nutritional Support: Total Parenteral Nutrition (TPN) if the obstruction persists beyond 5–7 days.
* Correction of Coagulopathy: Reversal of anticoagulants is mandatory.

Surgical Intervention

Surgery is reserved for cases that fail conservative management (usually >2 weeks of obstruction) or those with complications (perforation, hemorrhage, or associated organ injury).
* Procedure: Duodenotomy with evacuation of the hematoma.

Long-term Prognosis

The prognosis for isolated duodenal hematoma is excellent. Once the hematoma resorbs, there are typically no long-term sequelae. Patients should be monitored with follow-up imaging (usually a repeat CT or ultrasound) to ensure complete resolution of the mass.

8. Risks and Contraindications

• Risk of Perforation: Over-inflation or biopsy during endoscopy.
• Risk of Sepsis: If the hematoma becomes secondarily infected (very rare).
• Contraindication: Do not rush to surgery. The "watch and wait" approach is standard because the majority of these lesions resolve on their own, and surgery carries a higher risk of morbidity than conservative care.

9. FAQ Section (Frequently Asked Questions)

1. Is a duodenal hematoma the same as a duodenal ulcer?
No. An ulcer is an erosion of the mucosal lining, while a hematoma is a collection of blood within the wall layers, specifically the submucosa.

2. How long does it take for a duodenal hematoma to resolve?
Most hematomas resolve within 1 to 3 weeks with conservative management.

3. Why is there a delay in symptoms after trauma?
The hematoma often grows slowly. The patient may feel fine immediately after the trauma, but as the blood volume expands within the submucosal space, it eventually reaches a size that obstructs the duodenal lumen.

4. Can this happen in children?
Yes, it is a classic injury in children involved in bicycle accidents involving handlebars.

5. Is surgery always required?
No, surgery is rarely required. It is only indicated if the obstruction persists for a prolonged period or if there is evidence of perforation.

6. What is the role of ultrasound?
Ultrasound can be used, particularly in pediatric patients, to visualize the thickened duodenal wall and the hematoma, minimizing radiation exposure.

7. Can anticoagulants cause this spontaneously?
Yes, spontaneous intramural duodenal hematoma is a well-documented, though rare, complication of anticoagulant therapy.

8. What is the "target sign" on a CT scan?
It refers to the appearance of the duodenum where the center is hyperdense (blood) and the surrounding wall appears as a ring, signifying the intramural location of the mass.

9. Does diet change the outcome?
During the acute phase, the patient must be NPO. Once symptoms resolve, a gradual transition to clear liquids and then a low-residue diet is typically recommended.

10. What is the most dangerous complication?
The most dangerous complication is perforation, which leads to peritonitis and requires emergency surgical intervention.

10. Conclusion for Clinical Practitioners

The management of duodenal hematoma is a testament to the adage "less is more." In the absence of peritonitis or evidence of free perforation, clinicians should resist the urge to intervene surgically. By utilizing serial imaging and providing adequate supportive care (NG decompression and TPN), the vast majority of patients will achieve a full recovery. Awareness of this diagnosis, particularly in trauma patients or those on anticoagulants, is the primary key to avoiding unnecessary surgical exploration and improving patient outcomes.

Disclaimer: This guide is for educational purposes for medical professionals. Always consult the latest clinical guidelines and institutional protocols when managing complex trauma or surgical cases.